00000000nam 2200000zi 4500
0019.889902
003CaOODSP
00520221107172430
006m     o  d f      
007cr |n|||||||||
008200728e199110##onc     ob   f000 0|eng d
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aRG43-49/1991E-PDF
1001 |aLangford, Jock, |eauthor.
24514|aThe role of intellectual property in the competitiveness of the pharmaceutical sector : |b1991 pharmaceutical review / |cJock Langford, Dave Blaker and the Interdepartmental Working Group.
264 1|a[Ottawa] : |bIntellectual Property Review Branch, Consumer and Corporate Affairs Canada, |cOctober 1991.
300 |a1 online resource (72, 5 pages)
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |aDigitized edition from print [produced by Innovation, Science and Economic Development Canada].
504 |aIncludes bibliographical references.
650 0|aCompetition, International.
650 0|aDrugs|zCanada|xPatents.
650 0|aIntellectual property|zCanada.
650 0|aPharmaceutical industry|zCanada.
650 0|aCompulsory licensing of patents|zCanada.
650 6|aConcurrence internationale.
650 6|aMédicaments|zCanada|xBrevets d'invention.
650 6|aPropriété intellectuelle|zCanada.
650 6|aIndustrie pharmaceutique|zCanada.
650 6|aLicence obligatoire des brevets d'invention|zCanada.
7101 |aCanada. |bConsumer and Corporate Affairs Canada, |eissuing body.
85640|qPDF|s6.22 MB|uhttps://publications.gc.ca/collections/collection_2022/isde-ised/RG43-49-1991-eng.pdf